Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study : Dose Escalation of Intravenous Weekly Paclitaxel in Association With Metronomic Administration of Cyclophosphamide

NCT01374620 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT01374620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01374620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study : Dose Escalation of Intravenous Weekly Paclitaxel in Association With Metronomic Administration of Cyclophosphamide
Lead sponsor
Centre Oscar Lambret
Phase
Phase 1
Overall status
Completed
Start date
July 13, 2011
Completion date
April 30, 2013
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer